Stock Value
Competitors
| Ticker | Price | Forecast 1Y | Forecast 2Y | Market Cap | Div Yld | Growth Rate |
|---|---|---|---|---|---|---|
|
NYSE:ABBV
AbbVie
|
161.59 | -20.76% | -10.29% | 285,346.57 | 3.84% | 7.03% |
|
NasdaqGS:AMGN
Amgen
|
311.41 | -11.96% | -3.14% | 167,051.13 | 2.92% | 5.31% |
|
NasdaqGS:GILD
Gilead Sciences Inc
|
67.65 | 21.02% | 30.29% | 84,281.97 | 4.56% | 0.15% |
|
NasdaqGM:ALXN
Alexion Pharmaceuticals
|
182.50 | 0% | 0% | 40,336.01 | 0% | 0% |
|
NasdaqGS:BIIB
Biogen
|
226.88 | -13.85% | 1.44% | 33,033.02 | 0% | -10.89% |
|
NasdaqGS:BMRN
BioMarin Pharmaceutical
|
79.65 | 142.2% | 221.62% | 15,385.96 | 0% | 32.46% |
|
NasdaqGS:INCY
Incyte
|
57.05 | 104.81% | 153.29% | 12,012.93 | 0% | 27.62% |
|
NasdaqCM:VKTX
Viking Therapeutics
|
72.50 | 0% | 0% | 8,843.51 | 0% | 0% |
|
NasdaqGS:BPMC
Blueprint Medicines
|
105.46 | 0% | 0% | 6,783.92 | 0% | 0% |
|
NasdaqGM:ARNA
Arena Pharmaceuticals
|
99.99 | 0% | 0% | 6,165.32 | 0% | 0% |
|
NasdaqGM:IOVA
Iovance Biotherapeutics
|
10.72 | 0% | 0% | 3,763.74 | 0% | 0% |
|
NasdaqGS:CCXI
ChemoCentryx
|
51.99 | 0% | 0% | 3,739.11 | 0% | 0% |
|
NasdaqGS:CBAY
CymaBay Therapeutics
|
32.44 | 0% | 0% | 3,724.47 | 0% | 0% |
|
NasdaqGS:ARWR
Arrowhead Pharmaceuticals
|
22.91 | 0% | 0% | 3,062.73 | 0% | 0% |
|
NasdaqGM:DRNA
Dicerna Pharmaceuticals
|
38.01 | 0% | 0% | 2,986.1 | 0% | 0% |
|
NasdaqGM:FOLD
Amicus Therapeutics
|
9.33 | 0% | 0% | 2,807.75 | 0% | 0% |
|
NasdaqCM:CLDX
Celldex Therapeutics
|
39.47 | 0% | 0% | 2,631.15 | 0% | 0% |
|
NasdaqGS:ACAD
ACADIA Pharmaceuticals
|
14.86 | 0% | 0% | 2,512.75 | 0% | 0% |
|
NasdaqGM:VCEL
Vericel
|
48.53 | -94.78% | -76.15% | 2,364.47 | 0% | 0% |
|
NasdaqGM:ADMA
ADMA Biologics
|
9.16 | 0% | 0% | 2,042.24 | 0% | 0% |
